Pricing Log in Create free account

Clinuvel Pharmaceuticals Ltd. - Sponsored ADR (CUVL) vs Q32 Bio Inc. (QTTB)

Clinuvel Pharmaceuticals Ltd. - Sponsored ADR and Q32 Bio Inc. are both Biotechnology companies. Clinuvel Pharmaceuticals Ltd. - Sponsored ADR and Q32 Bio Inc. are of similar size ($276.8M and $257.5M).

Valuation

Metric CUVL QTTB Biotechnology median
P/E — 3.06 10.60
P/S — n/m 9.40
P/B — 1.78 2.13
Price to free cash flow — n/m 25.18
EV/EBITDA — n/m 0.66
EV/Sales — (13.54) 9.02
Earnings yield — 32.65% (32.88%)
Free cash flow yield — (6.86%) (23.13%)

Profitability

Metric CUVL QTTB Biotechnology median
Gross margin — 100.00% 68.51%
Operating margin — 0.00% 0.00%
Net margin — 0.00% 0.00%
Free cash flow margin — 0.00% 0.00%
Return on equity — 72.14% (51.96%)
Return on assets — 37.13% (46.06%)
Return on invested capital — 0.00% 0.00%

Growth

Metric CUVL QTTB Biotechnology median
Revenue growth (TTM) — (307.33%) 6.76%
EPS growth (last fiscal year) — 136.78% 29.88%
Revenue growth, 5-year CAGR — 100.32% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CUVL QTTB Biotechnology median
Debt to equity — 0.00 0.00
Current ratio — 20.30 4.97
Net debt to EBITDA — (2.21) 1.01

Dividend

Metric CUVL QTTB Biotechnology median
Dividend yield 0.56% — 0.41%
Payout ratio — — —

Size

Metric CUVL QTTB Biotechnology median
Market cap 257.50m 276.80m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack